5-Bromo-3-methyl-2-morpholinocarbonylpyridine, 95+%, 5g

4-Chloro-2-fluoro-6-methoxybenzoic acid, 95.0%, 100mg

N-(3-Hydroxypyridin-4-yl)-2,2-dimethylpropanamide, 97.0%, 250mg

2H-Benzimidazol-2-one, 1,3-dihydro-5-[3-[4-(phenylmethyl)-1-piperidinyl]-1-propyn-1-yl]-, 98%, 5mg

Recipiente de transporte Dewar Tipo BE (funda de acero inoxidable), 26 BE, 1 l, 100 mm, 1 Pieza

(1R*,4R*)-N1-(3-Methoxybenzyl)cyclohexane-1,4-diamine dihydrochloride, 1g

[(furan-2-yl)methyl][2-(1H-indol-3-yl)ethyl]amine hydrochloride, 95.0%, 10g

2-[4-(Aminomethyl)pyridin-2-yl]-1,2- thiazinane-1,1-dione dihydrochloride, 1g

Methyl 6-chloro-1H-pyrrolo[3,2-c]pyridine-3-carboxylate, 97%, 5g

1,4-DICHLOROANTHRAQUINONE, 98.0%, 1g

2-amino-5-iodo-4-methylnicotinonitrile, 98%, 1g

5'-METHOXYSPIRO[CYCLOPROPANE-1,1'-ISOINDOLIN]-3'-ONE, 95.0%, 250mg

tert-Butyl (3R)-3-[3-bromo-4-carbamoyl-5-(methylamino)pyrazol-1-yl]pyrrolidine-1-carboxylate, 98%, 1g